New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA

Published May 21, 2020

New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA

The FDA has approved PARP Inhibitor Olaparib for the treatment of advanced prostate cancer patients. Experts say this approval marks new personalized therapy options for specific tumors.

NOW
PLAYING
New Treatment Shows Huge Promise For Decreasing COVID Symptom-- Are Monoclonal Antibodies An Option for Cancer Patients?
NOW
PLAYING
There Is New Hope for Those Fighting the Same Cancer That Took John McCain & Ted Kennedy; Using Polio & Immunotherapy to Fight Brain Tumors
NOW
PLAYING
Singer Elvis Costello, 66, Quietly Beat Prostate Cancer 2 Years Ago; New Album Shows Resilience
NOW
PLAYING
Penny Lancaster, 49, Says Husband Rod Stewart's Prostate Cancer Diagnosis Led to 'Moments of Panic'
NOW
PLAYING
NBA Legend Abdul-Jabbar Fought Prostate Cancer, Now Calls for Better Healthcare for African Americans
NOW
PLAYING
Legendary Singer Frank Zappa Passed Nearly 27 Years Ago From Prostate Cancer; We've Seen Incredible Medical Advances Since Then

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.